IL205720A - Use of non-organic nitrite and its salts to catalyze blood vessels in chronic ischemia - Google Patents

Use of non-organic nitrite and its salts to catalyze blood vessels in chronic ischemia

Info

Publication number
IL205720A
IL205720A IL205720A IL20572010A IL205720A IL 205720 A IL205720 A IL 205720A IL 205720 A IL205720 A IL 205720A IL 20572010 A IL20572010 A IL 20572010A IL 205720 A IL205720 A IL 205720A
Authority
IL
Israel
Prior art keywords
salts
blood vessel
vessel growth
tissue ischemia
inorganic nitrite
Prior art date
Application number
IL205720A
Other languages
English (en)
Hebrew (he)
Other versions
IL205720A0 (en
Original Assignee
Univ Louisiana State
Uab Research Foundation
Biomedical Res Foundation Of Northwest Louisiana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Louisiana State, Uab Research Foundation, Biomedical Res Foundation Of Northwest Louisiana filed Critical Univ Louisiana State
Publication of IL205720A0 publication Critical patent/IL205720A0/en
Publication of IL205720A publication Critical patent/IL205720A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL205720A 2007-11-15 2010-05-12 Use of non-organic nitrite and its salts to catalyze blood vessels in chronic ischemia IL205720A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US315007P 2007-11-15 2007-11-15
PCT/US2008/083830 WO2009065142A2 (en) 2007-11-15 2008-11-17 Use of nitrite salts in chronic ischemia

Publications (2)

Publication Number Publication Date
IL205720A0 IL205720A0 (en) 2010-11-30
IL205720A true IL205720A (en) 2015-08-31

Family

ID=40639493

Family Applications (1)

Application Number Title Priority Date Filing Date
IL205720A IL205720A (en) 2007-11-15 2010-05-12 Use of non-organic nitrite and its salts to catalyze blood vessels in chronic ischemia

Country Status (7)

Country Link
US (2) US9649334B2 (OSRAM)
EP (1) EP2219657A4 (OSRAM)
JP (2) JP5795165B2 (OSRAM)
CN (1) CN101939014B (OSRAM)
AU (1) AU2008322437B2 (OSRAM)
IL (1) IL205720A (OSRAM)
WO (1) WO2009065142A2 (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
US20130209584A1 (en) * 2009-10-14 2013-08-15 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
US10463689B2 (en) 2009-10-14 2019-11-05 Board Of Supervisors Of Louisiana State University Pharmaceutical formulations of nitrite and uses thereof
WO2014130691A2 (en) * 2013-02-20 2014-08-28 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
US10517817B2 (en) 2013-05-09 2019-12-31 Syk Technologies, Llc Deep topical systemic nitric oxide therapy apparatus and method
WO2017132275A1 (en) 2016-01-27 2017-08-03 Syk Technologies, Llc Nitric oxide topical application apparatus and methods
JP7333919B2 (ja) 2017-09-05 2023-08-28 エクセル メッド、エルエルシー 虚血を治療するためのヘパリン組成物
PH12021551384A1 (en) 2019-01-02 2022-03-28 Celagenex Res India Pvt Ltd Synergistic nutritional compositions for pain management
US12459820B2 (en) 2020-06-11 2025-11-04 J. W. Randolph Miller Stabilized and NO2-inhibited nitric oxide generating gels for inhaled nitric oxide therapy

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2914446A (en) 1958-06-26 1959-11-24 Upjohn Co Nitrite stabilized ascorbic acid-cyanocobalamin compositions
US4650484A (en) 1983-02-03 1987-03-17 Alza Corporation Method for treating ischemic conditions
IE64726B1 (en) 1987-11-20 1995-08-23 Elan Corp Plc Pharmaceutical formulations for preventing drug tolerance
US5122384A (en) 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5278192A (en) 1992-07-02 1994-01-11 The Research Foundation Of State University Of New York Method of vasodilator therapy for treating a patient with a condition
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
US20110196039A9 (en) 1994-10-05 2011-08-11 Kaesemeyer Wayne H Controlled release arginine formulations
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
US5770645A (en) 1996-08-02 1998-06-23 Duke University Medical Center Polymers for delivering nitric oxide in vivo
US5994444A (en) 1997-10-16 1999-11-30 Medtronic, Inc. Polymeric material that releases nitric oxide
US7371415B1 (en) 1998-04-03 2008-05-13 The Daily Wellness Company Method and composition for improving sexual fitness
US7015876B1 (en) 1998-06-03 2006-03-21 Lear Corporation Heads-up display with improved contrast
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
WO2000003725A1 (en) 1998-07-14 2000-01-27 Paracelsian, Inc. Method for identifying and confirming consistent bio-functionality of natural compositions
DK1146862T3 (da) 1999-01-29 2003-07-21 Disphar Int Bv Farmaceutiske sammensætninger
GB9905425D0 (en) 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
US6314956B1 (en) 1999-09-08 2001-11-13 Duke University Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders
CN1299690C (zh) * 2000-07-28 2007-02-14 生物能量公司 用于提高心血管功能的组合物
GB0119011D0 (en) 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
AU2002357935A1 (en) 2001-12-18 2003-06-30 Alza Corporation Dosage form for providing time-varying patterns of drug delivery
EP1336602A1 (en) 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
CA2379211A1 (fr) 2002-03-28 2003-09-28 Institut De Cardiologie De Montreal Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase)
AU2004257693B8 (en) * 2003-07-09 2009-08-13 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
WO2005018561A2 (en) 2003-08-20 2005-03-03 Nitromed, Inc. Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
WO2005023189A2 (en) * 2003-09-03 2005-03-17 Pharmacia Corporation Method of cox-2 selective inhibitor and nitric oxide-donating agent
US7362274B1 (en) * 2004-07-09 2008-04-22 Huan-Cheng Lien Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna
US20060083824A1 (en) 2004-10-20 2006-04-20 Pbm Products Llc Nutritional supplements for glucose intolerant individuals
BRPI0610180A2 (pt) 2005-05-24 2012-09-25 Wellgen Inc métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação
NZ594596A (en) 2006-02-10 2011-10-28 Mannatech Inc All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
GB0607402D0 (en) 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
WO2007149520A2 (en) * 2006-06-21 2007-12-27 Albert Einstein College Of Medicine Of Yeshiva University Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof
EP3159000B1 (en) 2007-02-26 2025-05-21 HeartBeet Ltd. Performance enhancing composition
CA3187624A1 (en) 2007-02-26 2008-09-04 Heartbeet Ltd. New use of nitrites and nitrates and compositions containing these
WO2008153762A2 (en) 2007-05-25 2008-12-18 N30 Pharmaceuticals, Llc S-nitrosothiol formulations and storage systems
US9649334B2 (en) 2007-11-15 2017-05-16 The Uab Research Foundation Use of nitrite salts in chronic ischemia
AU2008345034A1 (en) 2007-12-27 2009-07-09 Aires Pharmaceuticals, Inc. Aerosolized nitrite and nitric oxide - donating compounds and uses thereof
WO2010036236A1 (en) 2008-09-23 2010-04-01 Baker Hughes Incorporated Anchor assembly
US8568793B2 (en) 2009-02-11 2013-10-29 Hope Medical Enterprises, Inc. Sodium nitrite-containing pharmaceutical compositions
WO2010147742A2 (en) 2009-06-18 2010-12-23 Theravasc Inc. Use of nitrite salts in treating tissue damage
US20130209584A1 (en) 2009-10-14 2013-08-15 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof
US10463689B2 (en) 2009-10-14 2019-11-05 Board Of Supervisors Of Louisiana State University Pharmaceutical formulations of nitrite and uses thereof
US20140127329A1 (en) 2011-03-31 2014-05-08 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline
WO2012142413A2 (en) 2011-04-14 2012-10-18 Theravasc Inc. Nitrite compositions and uses thereof
US9294956B2 (en) 2011-12-29 2016-03-22 Qualcomm Incorporated Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications
WO2014130691A2 (en) * 2013-02-20 2014-08-28 Theravasc Inc. Pharmaceutical formulations of nitrite and uses thereof

Also Published As

Publication number Publication date
AU2008322437B2 (en) 2013-11-07
JP2014139255A (ja) 2014-07-31
EP2219657A2 (en) 2010-08-25
US10864229B2 (en) 2020-12-15
JP2011503212A (ja) 2011-01-27
US9649334B2 (en) 2017-05-16
JP5795165B2 (ja) 2015-10-14
WO2009065142A2 (en) 2009-05-22
CN101939014A (zh) 2011-01-05
US20110311653A1 (en) 2011-12-22
JP5908527B2 (ja) 2016-04-26
CN101939014B (zh) 2016-04-27
AU2008322437A1 (en) 2009-05-22
IL205720A0 (en) 2010-11-30
EP2219657A4 (en) 2020-01-08
US20170312310A1 (en) 2017-11-02

Similar Documents

Publication Publication Date Title
IL205720A (en) Use of non-organic nitrite and its salts to catalyze blood vessels in chronic ischemia
IL281715A (en) Activin-ActrIIA antagonists and their use to increase bone growth in cancer patients
ZA201003057B (en) Use of umbilical cord blood in the treatment of premature birth complications
EP2142127A4 (en) DEVICES AND METHODS FOR THERMAL ABLATION OF BIOLOGICAL TISSUE USING GEOMETRIC ABLATION PATTERNS
EP2268209A4 (en) METHODS AND DEVICES FOR REDUCING TISSUE TRAUMATISM DURING SURGICAL INTERVENTION
EP2291110A4 (en) METHOD AND DEVICES FOR REDUCING TISSUE SPACE FOR OPERATIONS
GB2469227B (en) Inflatable pressurised medical chamber for use in bloodless surgery
IL214626A0 (en) Prodrug forms of kinase inhibitors and their use in therapy
IL206690A0 (en) Protein kinase inhibitors and their use in the preparation of medicaments
IL218851A0 (en) Use of dimiracetam in the treatment of chronic pain
PL2170877T3 (pl) Podstawione (oksazolidynon-5-ylometylo)-2-tiofenokarboksamidy i ich zastosowanie w dziedzinie krzepnięcia krwi
IL202307A0 (en) Multikinase inhibitors for use in the treatment of cancer
GB0610432D0 (en) Performance issues in use of vessels for biological applications
GB2453661B (en) In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
BRPI0913015A2 (pt) transportador de tecido para uso em cirurgias de redução gástrica e o método de uso associado
IL208653A0 (en) Medical devices for delivaring fluids during surgery and methods for their use
GB2463474B (en) Therapeutic bone growth and regeneration
WO2010147742A9 (en) Use of nitrite salts in treating tissue damage
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
EP2015717A4 (en) DEVICE FOR STABLE SPATIAL FIXING AND CENTRAL DRILLING WITH DISTAL LOCKING SCREWS IN EXTREMITY PROCESSES
BRPI0716148A2 (pt) aparelho de fornecimento e pràtese para vasos sanguÍneos
ZA201001817B (en) Crystalline hydrate of betamimetika and use as medicament thereof
WO2008124843A9 (en) Combined use of ultrasound and growth factors to stimulate bone formation
GB0602108D0 (en) Improvements in methods for diagnosis and treatment of vessel occlusion
IL214233A0 (en) Medical implement for manipulating sutures particulary useful in arthroscopic surgery

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed